You just read:

TB Alliance and Mylan Announce Global Collaboration to Commercialize Investigational Drug Pretomanid as Part of Two Regimens to Treat Tuberculosis (TB)

News provided by

Mylan N.V.

Apr 18, 2019, 08:00 ET